ECLLA Co-Founder Jan Rynne Joins European Discussion on the EU Biotech Act
ECLLA is proud to share that our Co-Founder, Jan Rynne, recently joined the Cancer Patients Europe (CPE) Policy Webinar as a panellist to discuss the EU Biotech Act and its potential to improve clinical trials and access to innovative cancer treatments across Europe....
ECLLA Club in Development – First Session Coming Soon
ECLLA Membership Club in Development – First Session Coming Soon ECLLA is pleased to share that preparations are underway for the first session of the ECLLA Club, a new initiative being developed exclusively for ECLLA member organisations. The Membership Club will...
🎥 ECLLA Expert Voices | European Policy Roundtable 2026 Reflections: Prof Oliver Karanfilski
European CLL Association – ECLLA is proud to work alongside Prof Oliver Karanfilski, Professor of Hematology and Internal Medicine and Consultant Hematologist from Macedonia, whose expertise brings an essential perspective to our Medical Advisory Board. At the...
ECLLA Co-Founder Michael Rynne Attends the Cancer Patients Europe Annual Meeting 2026
ECLLA Co-founder Michael Rynne attended the Cancer Patients Europe (CPE) Annual Meeting 2026, held in Brussels from 24–26 June under the theme “Protecting and Improving Europe’s Cancer Care Model in a Changing World.” The three-day meeting brought...